lysophosphatidic acid receptor 1(English)

• in the spotlight because its synthetic antagonist has been under clinical trials for lung fibrosis and psoriasis. Also a new etiological factor for cerebral ischemia, strongly indicating that its modulation can be a potential strategy to reduce ischemic brain damage
• MAPK, mRNA, shRNA, tMCAO
• Brain (dys)function, Hemodynamics
• https://doi.org…2974-019-1555-8